Left atrial appendage (LAA) closure using the Amplatzer cardiac plug is associated with lower than expected risks of systemic thromboembolism and major bleeding in patients with nonvalvular A-fib, ...

St. Jude Medical ($STJ) got sideswiped with an FDA safety alert over one of the company's heart plugs based on reports that it could potentially wear away tissue and ...

ST. PAUL, Minn. (AP) -- St. Jude Medical Inc. said Monday that the Food and Drug Administration approved the newest version of its Amplatzer vascular plug. The plug is designed to be used in surgical ...

MINNEAPOLIS, Aug. 24 AGA Medical Corporation ("AGA")announced today that it has received U.S. Food and Drug Administration (FDA)and European CE Mark approvals for the AMPLATZER Vascular Plug II ...

Abbott has received a new, broad approval from the FDA for its tiny heart plug implant to help cut down the risk of stroke among people with atrial fibrillation, the most common cardiac arrhythmia.

In high-risk patients with nonvalvular atrial fibrillation (A-fib), left atrial appendage (LAA) occlusion using a cardiac plug device can be safely performed and effectively prevents long-term stroke, ...

St. Jude Medical announced the first patient implant in a new pivotal trial evaluating the company’s AMPLATZER Cardiac Plug for the prevention of stroke. The AMPLATZER Cardiac Plug Clinical Trial is ...

First and only delivery system designed specifically for premature infants with a patent ductus arteriosus (PDA), a life-threatening opening in their heart New delivery system enables precise ...